Soyaklin

Capsules

 

Herbal Supplement for Troubles Associated with Menopause

 

 

A combination of 5 effective ingredients Glycine Max (Soya Isoflavones), Hypericum Perforatum (St. Johns Wort), Terminalia Arjuna and Yasad Bhasma and is indicated for improving the menopausal symptoms

 

Composition: Each capsule contains:

 

Glycine Max Extract 100 mg

(Standardized for Soya Isoflavone 40%)

 

Hypericum Perforatum Extract 100 mg

(Standardized for Hyperforin)

 

Terminalia Arjuna Extract 50 mg

(Standardized for Tannin Content 15%)

 

Yasas Bhasma 15 mg

(Standardized for elemental Zinc)

 

Excipients q.s.

 

Uses: According to the age-old scriptures of Ayurveda and other complementary and alternative systems, the herbal ingredients of this product are claimed to be useful in alleviating menopausal symptoms such as:

Mood Swings, Hot Flashes, Anxiety, Irritability, Headache, Depression, Palpitations, etc.

 

Dosage: One capsule two times a day or as directed by the physician

 

Contraindications: Not reported in recommended dosage

 

Precautions: No specific precautions

 

Presentation: HDPE pack of 60 capsules

 

Storage: Store in a cool dry place. Protect from light. Keep out of reach from children.

 

Price:  $44.95

 

 

Research References: (Primary Ingredients)

Soya

Messina M., Barnes S., The role of Soya products in reducing risk of cancer. J Natl Cancer Inst 1991, 83:541-546.

Tham DM, et al., Potential health benefits of dietary phytoestrogens-a review of the clinical, epidemiological and mechanistic evidence. J Clin Endocrinol Metab 1998, 83(7):2223-2235.

Lori C., et al. Antitumour Isoflavones in Soya bean foods from American and Asian Diets., J. Agric Food Chem. 1993, 41(11), 13.

Uckun, FM, et al. In vivo toxicity, pharmacokinetics and anticancer activity of genistein linked to recombinant human epidermal growth factor. Clin Cancer Res. 1998, 4(5):1125-1134.

Barnes S., The chemopreventive properties of Soya isoflavonoids in animal models of breast cancer. Lancet 1997, 350:990-994.

Griffiths K., Estrogens and prostatic disease; Prostate 2000, 45:87-100.

Gellar J, Sionit L, Partido C, Prostate 1998, 34:75-79.

Kuo SM, et al. Efficacy of antiprolferative flavonoids on ascorbic acid accumulation in human colon adenocarvinoma cells. Cancer Lett 1997,116(2):131-137.

 Record IR, et al. Genistein inhibits growth of B-16 melanoma cells in vivo and in vitro and promote differentiation in vitro. Int J Cancer 1997,72(5):860-864.

Li W, Weber G. Synergistic action of tiazofurin and genistein in human ovarian carcinoma cells. Oncology Res. 1998, 10(3):117-122.

Burke GL. The use of dietary Soya supplement as a post-menopausal hormone replacement therapy. Second Internation Symposium on the role of Soya in preventing and treating Chronic Diseases 1996. Sept 15-18 Brussells.

Yamaguchi M, Gao YH. Geinstein inhibits bone loss. Biochemical Pharmacology 1998, 55(1):71-76.

Arora A. et al. Antioxidant activities of isoflavones and their biologicals in liposomal system. Arch Biochem Biophys. 1998, 356(2):133-141.

Domonty I, Lamarche B, Deshaies Y, Jacques H. Role of Soyaisoflavones in the hypotriglyceridemic effect of Soya proteins in the rat. J Nutr. Biochem. 2002, 13(11):671-677.

Fukui K, Tachibana N, Wanezaki S, Shimoda T. Isoflavone-free Soya protein prepared by column chromatography reduces plasma cholesterol in rats. J Agriculture and Food Chemistry. 2002, 50(20):5717-5721.

Yamai M, Tsumura K, Kimura Y, Fukuda S, Murakami T, Kimura Y. Antiviral activityof a hot water extract of black Soya bean against a human respiratory illness virus. Bioscience, Biotechnology and Biochemistry 2003, 67(5):1071-1079.

Chavez M. Soyabeans as an alternative to hormone replacement therapy. J. Herbal Pharmacology 2001, 1(1):91-99.

Soung D, Khalil DA, Arquitt AB, Smith BJ, Hammond LJ, Droke EA, Lucas EA, Devareddy L, Arjmandi BH. Soy isoflavones prevent the ovarian hormone deficiency - associated rise in leukocytes in rats. Phytomedicine 2004, 11(4):303-309.